The Conundrum of Opioid Tapering in Long-Term Opioid Therapy for Chronic Pain: A Commentary
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Background: In response to the opioid epidemic and new guidelines, many patients on high-dose long term opioid therapy (LTOT) for chronic pain are getting tapered off opioids. As a result, a unique clinical challenge is emerging: while many on LTOT have poor pain control, functional decline, psychiatric instability, aberrancies and misuse, these issues may often worsen with opioid tapering. Currently, a clear explanation and practical guidance on how to manage this perplexing clinical scenario is lacking. Methods: We offer a commentary with our perspective on possible mechanisms involved in this clinical phenomena and offer practical management guidance, supported by available evidence. Results: It is not well recognized that allostatic opponent process involved in development of opioid dependence can cause worsening pain, functional status, sleep and psychiatric symptoms over time, and significant fluctuation of pain and other affective symptoms due to their bidirectional dynamic interaction with opioid dependence (‘affective dynamism’). These elements of complex persistent dependence (CPD), the grey area between simple dependence and addiction, can lead to escalating and labile opioid need, often generating aberrant behaviors. Opioid tapering, a seemingly logical intervention in this situation, may lead to worsening of pain, function and psychiatric symptoms due to development of protracted abstinence syndrome. We offer practicing clinicians management principles and practical guidance focused on management of CPD in addition to chronic pain in these difficult clinical scenarios. Conclusion: Awareness of the science of the neuroplasticity effects of repeated use of opioids is necessary to better manage these patients with complex challenges.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“At the cellular level tolerance occurs because of the drive to homeostatic balance, 2 involving de-sensitisation and down-regulation of MORs, as well as modifications to the mu-signalosome, neuronal proteome, transcriptome and neuronal morphology, 20 with consequent downstream effects on mesolimbic dopaminergic neurons.19,20”
From Tapering and withdrawing opioids: guidance informed by fundamental principles to minimise withdrawal symptoms (2025) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Withdrawal symptoms occur when opioids are reduced or stopped because the raised homeostatic set-point of the mu-opioid system registers reduced doses as ‘under activation’.2,20”
From Tapering and withdrawing opioids: guidance informed by fundamental principles to minimise withdrawal symptoms (2025) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Opioids produce their analgesic and dependency-forming effects through agonism of opioid receptors, and, most importantly, the MOR, with downstream effect on GABAergic and dopaminergic neurotransmission.2,19,20”
From Tapering and withdrawing opioids: guidance informed by fundamental principles to minimise withdrawal symptoms (2025) · cites this paper as [2]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Tolerance develops with repeated use whereby, as a result of changes at the metabolic or cellular level, the same dose produces less effect, or higher doses are required to achieve the same effect.2,20”
From Tapering and withdrawing opioids: guidance informed by fundamental principles to minimise withdrawal symptoms (2025) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“these periods of time likely reflect the time period required for adaptations of the opioid system to resolve.2,20,46,47”
From Tapering and withdrawing opioids: guidance informed by fundamental principles to minimise withdrawal symptoms (2025) · cites this paper as [2]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · JAMA · doi:10.1001/jama.2016.1464 · Cited by 5,161
Bardo, M. T., & Hammer, R. P. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90226-e · Cited by 3,219
CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6501e1 · Cited by 2,697
Alcoholism: Clinical and Experimental Research
(2010) · Alcoholism Clinical and Experimental Research · doi:10.1111/(issn)1530-0277 · Cited by 1,831
Opioid Abuse in Chronic Pain — Misconceptions and Mitigation Strategies
Volkow, N. D., & McLellan, A. T. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1507771 · Cited by 1,305
Addiction and the brain: The neurobiology of compulsion and its persistence
Hyman, S. E., & Malenka, R. C. (2001) · Nature Reviews Neuroscience · doi:10.1038/35094560 · Cited by 1,302
The opponent-process theory of acquired motivation: the costs of pleasure and the benefits of pain
Solomon, R. L. (1980) · American Psychologist · doi:10.1037/0003-066x.35.8.691 · Cited by 1,194
Neurobiological mechanisms for opponent motivational processes in addiction
Koob, G. F., & Le Moal, M. (2008) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2008.0094 · Cited by 702
Addiction as a stress surfeit disorder
Koob, G. F., Buck, C. L., Cohen, A., Edwards, S., Park, P. E., Schlosburg, J. E., Schmeichel, B., Vendruscolo, L. F., Wade, C. L., Whitfield, T. W., et al. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.024 · Cited by 483
Reward and motivation in pain and pain relief
Navratilova, E., & Porreca, F. (2014) · Nature Neuroscience · doi:10.1038/nn.3811 · Cited by 477
Research works printed but not linked: 6
- 10.1037/0033-295x.92.1.78 · doi:10.1037/0033-295x.92.1.78 · Paper page
- 10.15585/mmwr.rr6501e1 · DOI · Paper page
- Ballantyne JC, , Stannard C. New addiction criteria: diagnostic challenges persist in treating pain with opioids. Pain. 2013;1.
- SAMHSA. Protracted withdrawal. Substance abuse treatment advisory. 2010;9(1):1–8.
- Center for Substance Abuse T. SAMHSA/CSAT Treatment Improvement Protocols. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2004.
- VA/DoD Clinical Practive Guideleine Management of Opioid Therapy for Chronic pain. The Management of Opioid Therapy for Chronic Pain Working Group;2010.
Cited by
CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022
Dowell, D., Ragan, K. R., Jones, C. M., Baldwin, G. T., & Chou, R. (2022) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7103a1 · Cited by 1,886
Stigma as a fundamental hindrance to the United States opioid overdose crisis response
Tsai, A. C., Kiang, M. V., Barnett, M. L., Beletsky, L., Keyes, K. M., McGinty, E. E., Smith, L. R., Strathdee, S. A., Wakeman, S. E., & Venkataramani, A. S. (2019) · PLOS Medicine · doi:10.1371/journal.pmed.1002969 · Cited by 437
Agnoli, A., Xing, G., Tancredi, D. J., Magnan, E., Jerant, A., & Fenton, J. J. (2021) · JAMA · doi:10.1001/jama.2021.11013 · Cited by 273
Kroenke, K., Alford, D. P., Argoff, C., Canlas, B., Covington, E., Frank, J. W., Haake, K. J., Hanling, S., Hooten, W. M., Kertesz, S. G., et al. (2019) · Pain Medicine · doi:10.1093/pm/pny307 · Cited by 214
Babu, K. M., Brent, J. A., & Juurlink, D. N. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1807054 · Cited by 133
Lagisetty, P., Garpestad, C., Larkin, A., Macleod, C., Antoku, D., Slat, S., Thomas, J., Powell, V. D., Bohnert, A. S. B., & Lin, L. A. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108583 · Cited by 112
A crisis of opioids and the limits of prescription control: United States
Kertesz, S. G., & Gordon, A. J. (2018) · Addiction · doi:10.1111/add.14394 · Cited by 96
Clarke, H., Azargive, S., Montbriand, J., Nicholls, J., Sutherland, A., Valeeva, L., Boulis, S., McMillan, K., Ladak, S. S. J., Ladha, K., et al. (2018) · Canadian Journal of Pain · doi:10.1080/24740527.2018.1501669 · Cited by 84
Howell, B. A., Abel, E. A., Park, D., Edmond, S. N., Leisch, L. J., & Becker, W. C. (2021) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06339-3 · Cited by 75
Manhapra, A., & Becker, W. C. (2018) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.02.013 · Cited by 62
Self-citationManhapra, A., Sullivan, M. D., Ballantyne, J. C., MacLean, R. R., & Becker, W. C. (2020) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06251-w · Cited by 63
Self-citationPowell, V. D., Rosenberg, J. M., Yaganti, A., Garpestad, C., Lagisetty, P., Shannon, C., & Silveira, M. J. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.24152 · Cited by 55
Buprenorphine Microdose Induction for the Management of Prescription Opioid Dependence
Robbins, J. L., Englander, H. L., & Gregg, J. L. (2021) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2021.s1.200236 · Cited by 42
Stopping or Decreasing Opioid Therapy in Patients on Chronic Opioid Therapy
Pergolizzi, J. V., Varrassi, G., Paladini, A., & LeQuang, J. A. (2019) · Pain and Therapy · doi:10.1007/s40122-019-00135-6 · Cited by 42
Tapering opioids: a comprehensive qualitative review
Davis, M. P., Digwood, G., Mehta, Z., & McPherson, M. L. (2020) · Annals of Palliative Medicine · doi:10.21037/apm.2019.12.10 · Cited by 33
Quinlan, J., Willson, H., & Grange, K. (2020) · British Journal of Pain · doi:10.1177/2049463720974053 · Cited by 33
Complex Persistent Opioid Dependence—an Opioid-induced Chronic Pain Syndrome
Manhapra, A. (2022) · Current Treatment Options in Oncology · doi:10.1007/s11864-022-00985-x · Cited by 33
Self-citationDiagnosing Prescription Opioid Use Disorder in Patients Using Prescribed Opioids for Chronic Pain
Hasin, D. S., Shmulewitz, D., Stohl, M., Greenstein, E., Aharonovich, E., Petronis, K. R., Korff, M. V., Datta, S., Sonty, N., Ross, S., et al. (2022) · American Journal of Psychiatry · doi:10.1176/appi.ajp.21070721 · Cited by 34
Trøstheim, M., & Eikemo, M. (2024) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2024.2176 · Cited by 34
Ensuring Patient Protections When Tapering Opioids: Consensus Panel Recommendations
Covington, E. C., Argoff, C. E., Ballantyne, J. C., Cowan, P., Gazelka, H. M., Hooten, W. M., Kertesz, S. G., Manhapra, A., Murphy, J. L., Stanos, S. P., et al. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.04.025 · Cited by 31
Self-citationBuprenorphine in the Treatment of Chronic Pain
Rudolf, G. (2020) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/j.pmr.2020.02.001 · Cited by 28
Promoting Patient-Centeredness in Opioid Deprescribing: a Blueprint for De-implementation Science
Kertesz, S. G., McCullough, M. B., Darnall, B. D., & Varley, A. L. (2020) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06254-7 · Cited by 28
Chang, E. T., Oberman, R. S., Cohen, A. N., Taylor, S. L., Gumm, E., Mardian, A. S., Toy, S., Revote, A., Lewkowitz, B., & Yano, E. M. (2020) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06255-6 · Cited by 27
Long-term prescription opioid users' risk for new-onset depression increases with frequency of use
Scherrer, J. F., Salas, J., Miller-Matero, L. R., Sullivan, M. D., Ballantyne, J. C., DeBar, L., Grucza, R. A., Lustman, P. J., & Ahmedani, B. K. (2021) · Pain · doi:10.1097/j.pain.0000000000002547 · Cited by 27
Self-citationThe association of chronic pain and opioid withdrawal in men and women with opioid use disorder
Ware, O. D., Ellis, J. D., Dunn, K. E., Hobelmann, J. G., Finan, P. H., & Huhn, A. S. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109631 · Cited by 27
Behar, E., Bagnulo, R., Knight, K. R., Santos, G., & Coffin, P. O. (2020) · PLoS ONE · doi:10.1371/journal.pone.0230408 · Cited by 26
White, R., Hayes, C., Boyes, A., Chiu, S. K., & Paul, C. L. (2019) · Journal of Pain Research · doi:10.2147/jpr.s168785 · Cited by 25
Chang, H., Krawczyk, N., Schneider, K. E., Ferris, L. M., Eisenberg, M. D., Richards, T. M., Lyons, B. C., Jackson, K., Weiner, J. P., & Saloner, B. K. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.04.016 · Cited by 26
Schirle, L. M., Jeffery, A. D., Yaqoob, A., Sanchez‐Roige, S., & Samuels, D. C. (2021) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2021.104621 · Cited by 22
Becker, W. C., Krebs, E. E., Edmond, S. N., Lin, L. A., Sullivan, M. D., Weiss, R. D., & Gordon, A. J. (2020) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06260-9 · Cited by 21
Prescribing wellness: comprehensive pain management outside specialist services
Holliday, S., Hayes, C., Jones, L. E., Gordon, J., Harris, N., & Nicholas, M. K. (2018) · Australian Prescriber · doi:10.18773/austprescr.2018.023 · Cited by 20
Militello, L. G., Hurley, R. W., Cook, R. L., Danielson, E. C., Diiulio, J., Downs, S. M., Anders, S. H., & Harle, C. A. (2020) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06178-2 · Cited by 21
Nonconsensual Dose Reduction Mandates are Not Justified Clinically or Ethically: An Analysis
Kertesz, S. G., Manhapra, A., & Gordon, A. J. (2020) · The Journal of Law Medicine & Ethics · doi:10.1177/1073110520935337 · Cited by 20
Self-citationApproaches to opioid prescribing in cancer survivors: Lessons learned from the general literature
Jones, K. F., & Merlin, J. S. (2021) · Cancer · doi:10.1002/cncr.33961 · Cited by 19
Manhapra, A., MacLean, R. R., Rosenheck, R. A., & Becker, W. C. (2023) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15972 · Cited by 20
Self-citationGoudman, L., Moens, M., & Pilitsis, J. G. (2023) · Anesthesiology · doi:10.1097/aln.0000000000004863 · Cited by 18
Pain rehabilitation’s dual power: Treatment for chronic pain and prevention of opioid-related risks.
Crouch, T. B., Wedin, S., Kilpatrick, R. L., Christon, L., Balliet, W. E., Borckardt, J. J., & Barth, K. S. (2020) · American Psychologist · doi:10.1037/amp0000663 · Cited by 19
Opioid Prescribing and Suicide Risk in the United States
Olfson, M., Waidmann, T., King, M. D., Pancini, V., & Schoenbaum, M. (2023) · American Journal of Psychiatry · doi:10.1176/appi.ajp.22020102 · Cited by 17
Buprenorphine for Pain: A Narrative Review and Practical Applications
Spinella, S. A., & McCarthy, R. (2024) · The American Journal of Medicine · doi:10.1016/j.amjmed.2024.01.022 · Cited by 14
The drive to taper opioids: mind the evidence, and the ethics
Kertesz, S. G., & Manhapra, A. (2018) · Spinal Cord Series and Cases · doi:10.1038/s41394-018-0092-5 · Cited by 13
Self-citationA Brief Screening Tool for Opioid Use Disorder: EMPOWER Study Expert Consensus Protocol
You, D. S., Mardian, A. S., Darnall, B., Chen, C. A., Bruyne, K. D., Flood, P., Kao, M., Karnik, A. D., McNeely, J., Porter, J., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.591201 · Cited by 12
Primary care management of Long-Term opioid therapy
Coffin, P. O., Martinez, R. S., Wylie, B., & Ryder, B. (2022) · Annals of Medicine · doi:10.1080/07853890.2022.2121417 · Cited by 11
Kakko, J., Gedeon, C., Sandell, M., Grelz, H., Birkemose, I., Clausen, T., Rúnarsdóttir, V., Simojoki, K., Littlewood, R., Alho, H., et al. (2018) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-018-0160-7 · Cited by 10
“This may result in a perceived need for opioids or other medication for control of such symptoms [4].”
BackgroundOpioid tapering and mental health crisis in older adults
Maharjan, S., Ramachandran, S., Bhattacharya, K., Bentley, J. P., Eriator, I. I., & Yang, Y. (2023) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5698 · Cited by 10
Yarborough, B. J. H., Stumbo, S. P., Schneider, J. L., Ahmedani, B. K., Daida, Y. G., Hooker, S. A., Negriff, S. L., Rossom, R. C., & Lapham, G. T. (2023) · Journal of Pain · doi:10.1016/j.jpain.2023.11.002 · Cited by 10
Case, A. A., Walter, M., Pailler, M. E., Stevens, L., & Hansen, E. (2020) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2020.08.031 · Cited by 10
Is Nonconsensual Tapering of High-Dose Opioid Therapy Justifiable?
Rieder, T. N. (2020) · The AMA Journal of Ethic · doi:10.1001/amajethics.2020.651 · Cited by 10
Automating the Addiction Behaviors Checklist for Problematic Opioid Use Identification
Chatham, A. H., Bradley, E. D., Troiani, V., Beiler, D. L., Christy, P., Schirle, L. M., Sanchez‐Roige, S., Samuels, D. C., & Jeffery, A. D. (2025) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2025.0424 · Cited by 9
Problems with opioids - beyond misuse
Kheirabadi, D., Minhas, D., Ghaderpanah, R., & Clauw, D. J. (2024) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2024.101935 · Cited by 11
Scherrer, J. F., Salas, J., Grucza, R. A., Sullivan, M. D., Lustman, P. J., Copeland, L. A., & Ballantyne, J. C. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.09.089 · Cited by 9
Self-citationVarley, A. L., Goodin, B. R., Copes, H., Kertesz, S. G., Fontaine, K. R., Cherrington, A., & Hendricks, P. S. (2020) · Implementation Research and Practice · doi:10.1177/2633489520948859 · Cited by 8
Management of Chronic Pain in Patients with Substance Use Disorders
Eagen, K., Rabson, L., & Kellum, R. (2022) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2022.01.008 · Cited by 8
Pharmacologic Pain Management: What Radiation Oncologists Should Know
Skarf, L. M., Jones, K. F., Meyerson, J. L., & Abrahm, J. L. (2023) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2023.01.002 · Cited by 8
Edmond, S. N., Snow, J. L., Pomeranz, J. L., Cleve, R. V., & Becker, W. C. (2021) · Journal of Pain · doi:10.1016/j.jpain.2021.12.006 · Cited by 9
Williams, E. C., Frost, M. C., Bounthavong, M., Edmonds, A. T., Lau, M. K., Edelman, E. J., Harvey, M., & Christopher, M. L. D. (2024) · Substance Use & Addiction Journal · doi:10.1177/29767342241243309 · Cited by 8
Manhapra, A., Stefanovics, E. A., Rhee, T. G., & Rosenheck, R. A. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109339 · Cited by 7
Self-citationPowell, V. D., Macleod, C., Sussman, J. B., Lin, L. A., Bohnert, A. S. B., & Lagisetty, P. (2022) · Journal of General Internal Medicine · doi:10.1007/s11606-022-07732-w · Cited by 7
Timko, C., Lor, M. C., Kertesz, S. G., Kroenke, K., Macia, K. S., Nevedal, A., & Hoggatt, K. J. (2024) · Pain Practice · doi:10.1111/papr.13440 · Cited by 5
Yarborough, B. J. H., Stumbo, S. P., Schneider, J. L., Ahmedani, B. K., Daida, Y. G., Hooker, S. A., Lapham, G. T., Negriff, S. L., & Rossom, R. C. (2024) · Journal of Pain · doi:10.1016/j.jpain.2024.01.350 · Cited by 5
Hansen, E., Nadagoundla, C., Wang, C., Miller, A., & Case, A. A. (2019) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/1049909119884358 · Cited by 6
Dobbs, G. C., & Fogger, S. A. (2018) · Journal of Addictions Nursing · doi:10.1097/jan.0000000000000212 · Cited by 4
Kallman, T. F., Bäckryd, E., & Schaller, A. S. (2025) · Scientific Reports · doi:10.1038/s41598-025-15113-6 · Cited by 4
Roussin, A., Cissé, Z., Rousseau, V., Roche, G., Lestrade, C., Cauchie, A., Delage, N., Donnet, A., Obberghen, E. V., Wood, C. H., et al. (2024) · Therapies · doi:10.1016/j.therap.2024.01.008 · Cited by 3
Nøst, T. H., Skurtveit, S. O., Odsbu, I., Pedersen, L., Borchgrevink, P. C., & Handal, M. (2024) · Scandinavian Journal of Pain · doi:10.1515/sjpain-2024-0059 · Cited by 3
Bailey, J., Nafees, S. B., Jones, L., & Poole, R. (2020) · British Journal of Pain · doi:10.1177/2049463720958731 · Cited by 3
Wartko, P. D., Boudreau, D. M., Turner, J. A., Cook, A. J., Wellman, R., Fujii, M., Garcia, R., Moser, K. A., & Sullivan, M. D. (2021) · Contemporary Clinical Trials · doi:10.1016/j.cct.2021.106499 · Cited by 3
Bruneau, A., Sirois, A., Spiegler, G., Bi, J., Petkau, S., Djoudi, Y.-L., Ware, J., Alghamdi, R. I. A. D. N. A., Nipa, N., Perreault, M., et al. (2025) · Pain · doi:10.1097/j.pain.0000000000003753 · Cited by 2
Ballantyne, J. C., Sullivan, M. D., & Saxon, A. J. (2025) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001526 · Cited by 2
Self-citationTimko, C., Kroenke, K., Nevedal, A., Lor, M. C., Oliva, E. M., Drexler, K. P. G., Sandbrink, F., & Hoggatt, K. J. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-053524 · Cited by 3
Kral, L. A., Bettinger, J. J., Vartan, C. M., Hadlandsmyth, K., Kullgren, J. G., & Smith, M. A. (2022) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/15360288.2022.2041147 · Cited by 1
Hoggatt, K. J., Kroenke, K., Macia, K. S., Nevedal, A., Lor, M. C., Oliva, E. M., Breland, J. Y., & Timko, C. (2026) · Pain · doi:10.1097/j.pain.0000000000003924 · Cited by 1
Froentjes, L. S., Barrington, C., Craig, R., Morcos, M., Wedman, D., Korownyk, C. S., Kelmer, M. D., Campbell, F. N., & Garrison, S. (2026) · British Journal of General Practice · doi:10.3399/bjgp.2025.0705 · Cited by 1
Krashin, D. L., Murinova, N., & Ballantyne, J. C. (2020) · Springer eBooks · doi:10.1007/978-3-030-36391-8_37 · Cited by 1
Self-citationEnd Stage Chronic Pain (ESCP): Naming Complex Suffering in the Opioid Crisis Era
Comerci, G. D., Marr, L., & Finlay, E. E. (2020) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/1049909120969623 · Cited by 1
Abie Horowitz, M., Framer, A., Strang, J., & Taylor, D. (2025) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253251371504
“2,20 This concept is supported by the ability of MOR antagonists to induce withdrawal symptoms in individuals with physiological opioid dependence.”
InfluentialGordon, A. J., & Oliva, E. M. (2018) · Substance Abuse · doi:10.1080/08897077.2018.1518082
Long-term and high dose opioid medicine use in the U.K.
Harvey, J. E. (2018) · Nottingham ePrints (University of Nottingham)
Effective Opioid Analgesic Alternatives and Approaches to Pain Management
Goesling, J., & Ilgen, M. A. (2019) · Current clinical psychiatry · doi:10.1007/978-3-030-16257-3_12
Différence de perception de l’attachement aux antalgiques entre le médecin et le patient
Cantagrel, N., Lestrade, C., & Roussin, A. (2019) · Douleur et Analgésie · doi:10.3166/dea-2019-0066 · Cited by 1
Preoperative Management of Chronic Opioid Therapy
McAnally, H. B., & Darnall, B. D. (2019) · Oxford University Press eBooks · doi:10.1093/med/9780190920142.003.0010
Opioid utility and the clinician
Davis, M. P. (2020) · Annals of Palliative Medicine · doi:10.21037/apm.2020.03.06
Doleys, D. M., & Doleys, N. D. (2021) · Oxford University Press eBooks · doi:10.1093/med/9780197544631.003.0016
The Psychology of Opioid Tapering
Doleys, D. M., & Doleys, N. D. (2021) · Oxford University Press eBooks · doi:10.1093/med/9780197544631.003.0023
Tapering Opioids in Patients with Serious Illness: How to Taper #414
Jones, W. D., Junkins, S. R., & Rosielle, D. A. (2021) · Journal of Palliative Medicine · doi:10.1089/jpm.2020.0805
Mood Disturbances Associated with Long-Term Opioid Therapy #418
Case, A. A., & Davis, M. P. (2021) · Journal of Palliative Medicine · doi:10.1089/jpm.2021.0157
Finding a place for pain in medicine, in policy, and in life
Sullivan, M. D., & Ballantyne, J. C. (2023) · Oxford University Press eBooks · doi:10.1093/med/9780197615720.003.0009
Self-citation“A Profound, Abiding Hatred”: An Analysis of Hermann Goering’s Alleged Morphine Addiction
Turner, M. D. (2023) · Cureus · doi:10.7759/cureus.36865
A Group-Based Intervention to Reduce Opioid Use for Chronic Pain
Quinlan, J., & Wiech, K. (2023) · JAMA · doi:10.1001/jama.2023.13779
How Does the Opioid Epidemic Impact Palliative Medicine Practice?
merlin, K. F. J. J. S., & Childers, J. W. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-84702-5.00011-7
Opioid Taper and Complex Prescription Opioid Dependence: The Role of Depression
Lovejoy, T. I., & Zaccari, B. (2024) · Oxford University Press eBooks · doi:10.1093/9780197675250.003.0008
Manhapra, A., Rosenheck, R. A., & Becker, W. C. (2024) · Oxford University Press eBooks · doi:10.1093/9780197675250.003.0009
Self-citationOpioid use patterns and persistent use after hemodialysis access surgery
Copeland, T. P., Nahm, W. J., Woo, K., Wisk, L. E., Dworsky, J. Q., Martin, E. J., & Ku, E. (2025) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2025.05.207
The Practice of Prescribing Opioids : Insights from Registries, Biomarkers, and Interviews
Kallman, T. F. (2025) · Linköping University medical dissertations · doi:10.3384/9789181181333
Pierson, C. J., Khodaparast, N., McWade, M. A., Kuo, Y., Houghton, D. C., Rodriguez, S. L., Korschgen, V. L., Cunningham, K. A., & Wilkes, D. M. (2025) · Trials · doi:10.1186/s13063-025-09171-4
Fu, R., Bean, D. J., Morenga, L. T., Frei, D. R., & Devan, H. (2025) · Journal of Pain Research · doi:10.2147/jpr.s535298
Patient Profiles of Buprenorphine Initiators in General Healthcare Settings: A Latent Class Approach
Grucza, R. A., Salas, J., Xu, K. Y., Bello, J. K., Gebauer, S., Veeramachaneni, K., Rottnek, F., & Scherrer, J. F. (2026) · Journal of General Internal Medicine · doi:10.1007/s11606-026-10221-z
Macleod, C., Logue, C., Kumbier, K. E., Shaw, M. A., Henneman, J., Kehne, A., Jarzebowski, M., Powell, V. D., Sussman, J. B., Bohnert, A. S. B., et al. (2026) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2026.113080
Smith, B. L., Winstel, G., Brooks-Patton, B., Makela, A. G., Osifalujo, B., Raleigh, N., Akindiose, B., Mitchell, C., Taylor, M. E., & Cosby, K. L. (2026) · NeuroToxicology · doi:10.1016/j.neuro.2026.103505
Conceptualizing and treating the polytrauma clinical triad as a complex chronic pain syndrome
Manhapra, A., Kennedy, E., Cifu, D. X., Miles, S. R., & Pugh, M. J. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1752206
Self-citation
Metadata
- Authors
- Manhapra, A., Arias, A. J., & Ballantyne, J. C.
- Affiliations
- Yale University (US)
- University of Washington (US)
- Corresponding author
- Manhapra, Ajay
- Venue
- Substance Abuse
- Publisher
- SAGE Publications
- Published
- 2018-04
- Volume
- 39
- Issue
- 2
- Pages
- 152-161
- ISSN
- 0889-7077 (ISSN-L)
- 1547-0164
- PMC
- PMC6129223
- OpenAlex
- W2755855796
- Cited by
- 98
- References
- 57
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 10 · 2023: 11 · 2022: 10 · 2021: 15 · 2020: 21 · 2019: 9 · 2018: 9
- FWCI
- 10.02
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Substance Abuse (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Drug Abuse (R25DA033211)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Pain Management
- Keywords
- opioid tapering, long-term opioid therapy, chronic pain, opioid use disorder, opponent process theory, withdrawal syndrome, pain fluctuation, psychiatric symptoms, functional decline, opioid misuse, opioid epidemic, neuroplasticity
- MeSH terms
- Analgesics, Opioid, Drug Administration Schedule, Humans, Opioid-Related Disorders, Withholding Treatment, Chronic Pain, Pain Management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.